Skip to main content

Table 1 Patient characteristics with advanced NSCLC

From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

  N = 173 (%)
Age (median, range) 57 (34–88)
SEX  
Male 116 (67)
Female 57 (33)
RACE  
African American 90 (52)
White 83 (48)
Performance status (PS)  
0-1 130 (76)
2-4 42 (24)
Histology  
Adenocarcinoma 91 (52)
Non-adenocarcinoma 82 (47)
Number of metastatic sites  
1-2 93 (54)
>2 80 (46)
Chemotherapy  
No chemo 59 (34)
Any chemo 114 (66)
First response assessment  
Response to chemotherapy 41 (23)
Stable disease 24 (14)
Progression 39 (23)
Decline in performance status 69 (40)
Survival (months)  
Median progression free survival 3.7
Median overall survival 5.1
  1. NSCLC: Non-small cell lung cancer.